About this trial
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
Eligibility criteria
Qualifiers
For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.
Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.
All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.
Participants who can attend the scheduled meetings and interventions as per the study protocol.
Disqualifiers
For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years.
Individuals unwilling to provide consent for participation.
Participants with reported health conditions that may hinder their active involvement in the study.
Individuals with non-compliance with research protocols
Trial design
Treatments tested in this trial
- PLA
Treatment groups
Sponsors and collaborators
HealthNet Transcultural Psychosocial Organization
Lead sponsor
University of York
Collaborator
Khyber Medical University Peshawar
Collaborator
National Institute for Health Research, United Kingdom
Collaborator
Aga Khan University
Collaborator